1.B7-3 targetedantibody-based immunotherapy of malignant diseases. Expert Opin Biol Ther. 2020Dec 21;1-16. 2.B7-H3 role in theimmune landscape of cancer. Am J Clin Exp Immunol. 2017; 6(4): 66–75. 3.NK-Cell-MediatedTargeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer...
1.B7-3 targetedantibody-based immunotherapy of malignant diseases. Expert Opin Biol Ther. 2020Dec 21;1-16. 2.B7-H3 role in theimmune landscape of cancer. Am J Clin Exp Immunol. 2017; 6(4): 66–75. 3.NK-Cell-MediatedTargeting of Various Solid Tumors Using...
1.B7-3 targetedantibody-based immunotherapy of malignant diseases. Expert Opin Biol Ther. 2020Dec 21;1-16. 2.B7-H3 role in theimmune landscape of cancer. Am J Clin Exp Immunol. 2017; 6(4): 66–75. 3.NK-Cell-MediatedTargeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer...
[7]Theodoros Michelakos, et al. B7-H3 targeted antibody-based immunotherapy of malignant diseases. Expert Opinion on Biological Therapy, https://doi.org/10.1080/14712598.2021.1862791 [8] Jose R Castellanos, et al . B7-H3 role in the immune landsc...
2.B7-H3 role in theimmune landscape of cancer. Am J Clin Exp Immunol. 2017; 6(4): 66–75. 3.NK-Cell-MediatedTargeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager InVitro and In Vivo. Cancers (Basel). 2020 Sep 18;12(9):2659....
2.B7-H3 role in theimmune landscape of cancer. Am J Clin Exp Immunol. 2017; 6(4): 66–75. 3.NK-Cell-MediatedTargeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager InVitro and In Vivo. Cancers (Basel). 2020 Sep 18;12(9):2659....
1.B7-3 targetedantibody-based immunotherapy of malignant diseases. Expert Opin Biol Ther. 2020Dec 21;1-16. 2.B7-H3 role in theimmune landscape of cancer. Am J Clin Exp Immunol. 2017; 6(4): 66–75. 3.NK-Cell-MediatedTargeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer...
2.B7-H3 role in theimmune landscape of cancer. Am J Clin Exp Immunol. 2017; 6(4): 66–75. 3.NK-Cell-MediatedTargeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager InVitro and In Vivo. Cancers (Basel). 2020 Sep 18;12(9):2659. ...
2.B7-H3 role in theimmune landscape of cancer. Am J Clin Exp Immunol. 2017; 6(4): 66–75. 3.NK-Cell-MediatedTargeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager InVitro and In Vivo. Cancers (Basel). 2020 Sep 18;12(9):2659....
[8] Jose R Castellanos, et al . B7-H3 role in the immune landscape ofcancer. Am J Clin Exp Immunol 2017;6(4):66-75 [9] 高春涛, 等. B7-H3在肿瘤免疫中的研究进展. 国际生物医学工程, 2020,43(4): 324-328 [10] Yi Li, et al. B7-H3 promotes the proliferation, migration andinvasi...